US Announces Negotiated Prices for 15 Expensive Drugs

The U.S. government is set to announce negotiated prices for fifteen expensive prescription drugs covered by Medicare, marking a significant step towards lowering healthcare costs. Novo Nordisks GLP-one drugs, Wegovy and Ozempic, will see their Medicare prices drop to $245 a month next year. Other drugs like GSKs Trelegy Ellipta and AbbVies Linzess are also up for negotiation. Experts predict these negotiations will lead to real savings, potentially lowering drug costs across the board. This move comes after the Inflation Reduction Act allowed Medicare to negotiate drug prices, a practice previously prohibited. The Daily News Now! - Every city. Every story. AI Powered. Hosted on Acast. See acast.com/privacy for more information.